Kevin Pak, MD
NPI 1427558048ActiveIndividual· Internal Medicine, Transplant Hepatology· Fort Sam Houston, TX
Internal Medicine, Transplant Hepatology (MD) in Fort Sam Houston, Texas, licensed in CA, with an NPI issued in February 2018. Ipsen Biopharmaceuticals, Inc was the largest of 8 companies reporting payments in 2025, $2,133 in all, mostly food and beverage.
Overview
| NPI | 1427558048 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Feb 20, 2018 |
| Last updated in NPPES | Jul 2, 2025 |
| Certified by provider | Jul 2, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Transplant Hepatology Primary | 207RT0003X | A192767 | CA |
| Internal Medicine, Gastroenterology | 207RG0100X | A192767 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$2,133 · 15 payments from 8 companies
- 2024$725.20 · 9 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $1,020 | 3 |
| Gilead Sciences, Inc. | $337.38 | 3 |
| Madrigal Pharmaceuticals | $245.12 | 4 |
| Alnylam Pharmaceuticals Inc. | $149.21 | 1 |
| Mirum Pharmaceuticals, Inc. | $141.52 | 1 |
What the 2025 payments were for
- Food and Beverage$1,313 · 14 payments
- Travel and Lodging$820.13 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records